Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.

ABSTRACT:

SUBMITTER: Cunningham D 

PROVIDER: S-EPMC5337626 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature